Literature DB >> 23272908

Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.

Wenxing Chen1, Yin Lu, Guangying Chen, Shile Huang.   

Abstract

Cryptotanshinone is one of the major tanshinones isolated from the roots of the plant Salvia miltiorrhiza Bunge (Danshen). Danshen has been widely used in traditional Chinese medicine for treatment of a variety of diseases, including coronary artery disease, acute ischemic stroke, hyperlipidemia, chronic renal failure, chronic hepatitis, and Alzheimer's disease, showing no serious adverse effects. Recent studies have shown that cryptotanshinone not only possesses the potential for treatment and prevention of the above-mentioned diseases, but also is a potent anticancer agent. Here we briefly summarize the physical and chemical properties and the pharmacokinetic profiles of cryptotanshinone, and then comprehensively review its anticancer activities as well as the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23272908      PMCID: PMC3625674          DOI: 10.2174/18715206113139990115

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  73 in total

Review 1.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

2.  Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.

Authors:  S Hashemolhosseini; Y Nagamine; S J Morley; S Desrivières; L Mercep; S Ferrari
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

3.  Cryptotanshinone but not tanshinone IIA inhibits angiogenesisin vitro.

Authors:  Jong Moon Hur; Joong Sup Shim; Hye Jin Jung; Ho Jeong Kwon
Journal:  Exp Mol Med       Date:  2005-04-30       Impact factor: 8.718

4.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

5.  Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.

Authors:  Xinming Yang; Yuehui Zhang; Xiaoke Wu; Chun Sik Bae; Lihui Hou; Haixue Kuang; Yongyan Wang; Elisabet Stener-Victorin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 6.  Targeting oxidative stress in cancer.

Authors:  Matthew W Lawless; Kenneth J O'Byrne; Steven G Gray
Journal:  Expert Opin Ther Targets       Date:  2010-11       Impact factor: 6.902

7.  Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells.

Authors:  Wenxing Chen; Lei Liu; Yan Luo; Yoshinobu Odaka; Sanket Awate; Hongyu Zhou; Tao Shen; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2012-04-03

8.  Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells.

Authors:  Faisal Thayyullathil; Shahanas Chathoth; Abdulkader Hago; Mahendra Patel; Sehamuddin Galadari
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

9.  PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation.

Authors:  Eun-Jeon Park; Yu-Zhe Zhao; Youn-Chul Kim; Dong Hwan Sohn
Journal:  Food Chem Toxicol       Date:  2007-04-21       Impact factor: 6.023

10.  Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.

Authors:  Nguyen Tien Dat; Xuejun Jin; Jeong-Hyung Lee; Dongho Lee; Young-Soo Hong; Kyeong Lee; Young Ho Kim; Jung Joon Lee
Journal:  J Nat Prod       Date:  2007-06-21       Impact factor: 4.050

View more
  37 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).

Authors:  Wei Liu; Bing Yu; Gang Xu; Wei-Ren Xu; Mignon L Loh; Li-Da Tang; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2013-09-04       Impact factor: 7.446

3.  Inhibition of PI3K/Akt/mTOR signaling by natural products.

Authors:  Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

4.  Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells.

Authors:  Yong Cao; Bin Huang; Changqing Gao
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

5.  Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways.

Authors:  Wenwen Zhao; Chuanhong Wu; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2015-12-08       Impact factor: 3.405

6.  Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.

Authors:  Alicia M Blessing; Janice M Santiago-O'Farrill; Weiqun Mao; Lan Pang; Jing Ning; Daewoo Pak; Lakshmi Reddy Bollu; Philip Rask; LaKesla Iles; Hailing Yang; Samantha Tran; Ezzeddine Elmir; Geoffrey Bartholomeusz; Robert Langley; Zhen Lu; Robert C Bast
Journal:  Cancer       Date:  2020-06-02       Impact factor: 6.860

7.  HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.

Authors:  Qinyuan Zhu; Yanzhou Zhang; Jiekun Xuan; Fanping Yang; Binbin Du; Sheng-An Chen; Sijia Yan; Menglin Jiang; Huizhong Zhu; Hao Xiong; Xiaoqun Luo; Qinghe Xing
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

8.  Glutaminyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization, structure, and development as a screening platform.

Authors:  Yaritza Escamilla; Casey A Hughes; Jan Abendroth; David M Dranow; Samantha Balboa; Frank B Dean; James M Bullard
Journal:  Protein Sci       Date:  2019-12-24       Impact factor: 6.725

9.  LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway.

Authors:  Su-Zhen Zhou; Han Li; Zhi-Wan Wang; Ming-Hang Wang; Ning Li; Yan-Fang Wang
Journal:  Cell Cycle       Date:  2020-10-16       Impact factor: 4.534

Review 10.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.